OTC
IBB icon

Opera Trading Capital’s iShares Biotechnology ETF IBB Stock Holding History

Opera Trading Capital’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-2,547
Closed -$245K – 122
2016
Q3 		$245K Buy
2,547
+1,476
+138% +$140K 0.05% 89
2016
Q2 		$92K Sell
1,071
-8,190
-88% -$735K 0.02% 98
2016
Q1 		$805K Buy
9,261
+2,667
+40% +$239K 0.21% 69
2015
Q4 		$743K Buy
+6,594
New +$716K 0.16% 57

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Opera Trading Capital's IBB Position: Q4 2016 in Review

Opera Trading Capital sold out of iShares Biotechnology ETF (IBB) in Q4 2016, closing a stake of 2,547 shares — an estimated $245K sold.

Opera Trading Capital first reported a position in IBB in Q4 2015 and held it in 4 quarters. The position peaked at $805K in Q1 2016. 522 funds tracked by Wall St. Rank hold IBB as of Q4 2016.

  • Opera Trading Capital reported no remaining iShares Biotechnology ETF position as of Q4 2016 after selling out during the quarter.
  • Opera Trading Capital sold 2,547 iShares Biotechnology ETF shares in Q4 2016, an estimated $245K.
  • Opera Trading Capital first reported a position in iShares Biotechnology ETF in Q4 2015 and held it in 4 quarters.
  • Opera Trading Capital's iShares Biotechnology ETF position peaked at $805K in Q1 2016.
  • 522 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2016.

Based on Opera Trading Capital's 13F filing for Q4 2016, filed 10 Feb 2017.